結果ページ11 セクター：医療 産業：バイオテクノロジー 株式市場―見積もりと価格
価格、時価総額、PE、EPSを含む全株式と自己資本のリスト
すべての国
- {{country.name}}
- すべての国
- 米国 (656)
- オーストラリア (49)
- オーストリア (11)
- ベルギー (6)
- ブラジル (14)
- カナダ (48)
- 中国 (91)
- デンマーク (5)
- フィンランド (4)
- フランス (27)
- ドイツ (449)
- 香港 (46)
- インド (19)
- イスラエル (12)
- イタリア (3)
- 日本 (37)
- メキシコ (22)
- オランダ (3)
- ニュージーランド (1)
- ノルウェー (10)
- ポーランド (8)
- ロシア (2)
- 韓国 (20)
- スペイン (4)
- スウェーデン (55)
- スイス (8)
- 台湾 (60)
- タイ (2)
- トルコ (1)
- イギリス (24)
全取引所
- {{item.name}}
- 全取引所
- Amsterdam (3)
- ASX (49)
- Brussels (6)
- BSE (9)
- Canadian Sec (21)
- Cboe CA (3)
- Copenhagen (5)
- Frankfurt (395)
- Helsinki (4)
- HKSE (46)
- IOB (24)
- Istanbul (1)
- KOSDAQ (10)
- KSE (10)
- MCE (4)
- MCX (2)
- Mexico (22)
- Milan (3)
- Munich (17)
- NSE (10)
- NYSE (6)
- NYSE American (14)
- NZSE (1)
- Oslo (10)
- OTC Markets EXMKT (41)
- OTC Markets OTCPK (107)
- OTC Markets OTCQB (30)
- OTC Markets OTCQX (6)
- Paris (27)
- São Paulo (14)
- Shanghai (46)
- Shenzhen (45)
- Stockholm (55)
- Stuttgart (24)
- Swiss (8)
- Taipei Exchange (53)
- Taiwan (7)
- Tech Market Large (156)
- Tech Market Middle (85)
- Tech Market Small (211)
- Tel Aviv (12)
- Thailand (2)
- Tokyo (37)
- Toronto (8)
- TSXV (16)
- Vienna (11)
- Warsaw (8)
- XETRA (13)
バイオテクノロジー (1697)
| 名前 名前 | 価格 価格 |
24h% 7d chart 24h% & 7d |
時価総額 時価総額 | 出来高 出来高 | 過去24時間底値 | 過去24時間高値 | 時価総額 | PER (株価収益率) | 1株当たり利益 | 予測 |
|---|
| 名前 名前 | 価格 価格 |
24h% 7d chart 24h% & 7d |
時価総額 時価総額 | 出来高 出来高 | 過去24時間底値 | 過去24時間高値 | 時価総額 | PER (株価収益率) | 1株当たり利益 | 予測 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.pe }} | {{ item.eps }} {{ item.eps_usd }} |
|
|
| Ascendis Pharma A/S A1SN34.SA | R$70.21 14.23 USD |
0
|
R$64.94B 13.16B USD | R$0.00 0 USD | R$70.21 14.23 USD | R$70.21 14.23 USD | R$64.94B 13.16B USD | 0 | -R$23.76 -4.8 USD | ||
| Roivant Sciences Ltd. 87S.F | €17.30 18.91 USD |
+1.2
|
€12.03B 13.15B USD | €20.00 21.86 USD | €17.30 18.91 USD | €17.47 19.1 USD | €12.03B 13.15B USD | 0 | -€0.86 -0.9 USD | ||
| Akeso, Inc. 4RY.F | €12.70 13.88 USD |
+0.79
|
€11.91B 13.02B USD | €400.00 437.25 USD | €12.70 13.88 USD | €12.80 13.99 USD | €11.91B 13.02B USD | 0 | -€0.12 -0.1 USD | ||
| BridgeBio Pharma, Inc. 2CL.F | €61.70 67.45 USD |
+2.22
|
€11.89B 13B USD | €40.00 43.73 USD | €61.08 66.77 USD | €61.70 67.45 USD | €11.89B 13B USD | 0 | -€3.66 -4.0008 USD | ||
| Madrigal Pharmaceuticals, Inc. YDO1.F | €509.20 556.62 USD |
0
|
€11.56B 12.64B USD | €32.00 34.98 USD | €492.30 538.15 USD | €509.20 556.62 USD | €11.56B 12.64B USD | 0 | -€11.19 -12.2 USD | ||
| Ionis Pharmaceuticals, Inc. IONS.MX | MX$1,150.00 68.09 USD |
0
|
MX$210.20B 12.45B USD | MX$0.00 0 USD | MX$1,150.00 68.09 USD | MX$1,150.00 68.09 USD | MX$210.20B 12.45B USD | 0 | -MX$29.78 -1.7 USD | ||
| Ascendis Pharma A/S A71.F | €182.00 198.95 USD |
-1.09
|
€11.12B 12.16B USD | €15.00 16.4 USD | €179.00 195.67 USD | €182.00 198.95 USD | €11.12B 12.16B USD | 0 | -€3.83 -4.1 USD | ||
| BioMarin Pharmaceutical Inc. B1MR34.SA | R$144.06 29.2 USD |
0
|
R$56.08B 11.37B USD | R$0.00 0 USD | R$144.06 29.2 USD | R$144.06 29.2 USD | R$56.08B 11.37B USD | 19.81 | R$7.27 1.47 USD | ||
| BioMarin Pharmaceutical Inc. BMRN.MX | MX$980.00 58.03 USD |
0
|
MX$190.85B 11.3B USD | MX$0.00 0 USD | MX$980.00 58.03 USD | MX$980.00 58.03 USD | MX$190.85B 11.3B USD | 19.72 | MX$49.69 2.94 USD | ||
| Exelixis, Inc. EX9.F | €36.28 39.66 USD |
-1.06
|
€10.13B 11.07B USD | €300.00 327.94 USD | €36.28 39.66 USD | €36.28 39.66 USD | €10.13B 11.07B USD | 17.52 | €2.07 2.26 USD | ||
| Bio-Techne Corporation TECH.MX | MX$1,174.55 69.55 USD |
+3.2
|
MX$186.63B 11.05B USD | MX$0.00 0 USD | MX$1,090.00 64.54 USD | MX$1,090.00 64.54 USD | MX$186.63B 11.05B USD | 46.24 | MX$25.40 1.5 USD | ||
| Moderna, Inc. MRNA.MX | MX$455.00 26.94 USD |
+1.74
|
MX$179.93B 10.65B USD | MX$402.00 23.8 USD | MX$450.00 26.65 USD | MX$455.00 26.94 USD | MX$179.93B 10.65B USD | 0 | -MX$148.90 -8.8 USD | ||
| Jazz Pharmaceuticals plc J7Z.F | €155.65 170.15 USD |
-0.86
|
€9.46B 10.34B USD | €4.00 4.37 USD | €153.55 167.85 USD | €156.85 171.46 USD | €9.46B 10.34B USD | 0 | -€5.35 -5.8 USD | ||
| BioMarin Pharmaceutical Inc. BM8.F | €47.96 52.43 USD |
+1.29
|
€9.45B 10.33B USD | €108.00 118.06 USD | €47.96 52.43 USD | €47.96 52.43 USD | €9.45B 10.33B USD | 20.49 | €2.34 2.56 USD | ||
| BioMarin Pharmaceutical Inc. BMRN.VI | €48.57 53.09 USD |
+2.68
|
€9.43B 10.31B USD | €0.00 0 USD | €48.01 52.48 USD | €48.57 53.09 USD | €9.43B 10.31B USD | 20.75 | €2.34 2.56 USD | ||
| Bio-Techne Corporation T1CH34.SA | R$10.74 2.18 USD |
+0.09
|
R$50.20B 10.18B USD | R$0.00 0 USD | R$10.74 2.18 USD | R$10.74 2.18 USD | R$50.20B 10.18B USD | 119.33 | R$0.09 0.02 USD | ||
| Financière de Tubize SA FTD.F | €203.00 221.91 USD |
+0.5
|
€9.04B 9.88B USD | €100.00 109.31 USD | €203.00 221.91 USD | €203.00 221.91 USD | €9.04B 9.88B USD | 97.59 | €2.08 2.27 USD | ||
| Financière de Tubize SA FTD.SG | €201.50 220.27 USD |
-0.98
|
€8.97B 9.8B USD | €0.00 0 USD | €201.50 220.27 USD | €204.00 223 USD | €8.97B 9.8B USD | 96.87 | €2.08 2.27 USD | ||
| Bio-Techne Corporation TE1.F | €56.50 61.76 USD |
+2.73
|
€8.80B 9.62B USD | €4.00 4.37 USD | €54.50 59.58 USD | €56.50 61.76 USD | €8.80B 9.62B USD | 134.52 | €0.42 0.46 USD | ||
| ABIVAX Société Anonyme 2X1.F | €110.40 120.68 USD |
+5.34
|
€8.61B 9.41B USD | €50.00 54.66 USD | €108.20 118.28 USD | €110.40 120.68 USD | €8.61B 9.41B USD | 0 | -€3.09 -3.3 USD | ||
| Moderna, Inc. MRNA.VI | €21.14 23.11 USD |
+2.13
|
€8.50B 9.29B USD | €1.56K 1.71K USD | €20.83 22.77 USD | €21.17 23.14 USD | €8.50B 9.29B USD | 0 | -€6.99 -7.6 USD | ||
| Moderna, Inc. 0QF.MU | €21.03 22.99 USD |
+2.91
|
€8.38B 9.16B USD | €1.00K 1.09K USD | €20.73 22.66 USD | €21.03 22.99 USD | €8.38B 9.16B USD | 0 | -€7.01 -7.6 USD | ||
| Moderna, Inc. 0QF.F | €21.03 22.99 USD |
-0.12
|
€8.27B 9.04B USD | €636.00 695.23 USD | €20.64 22.56 USD | €21.03 22.99 USD | €8.27B 9.04B USD | 0 | -€7.00 -7.6 USD | ||
| Halozyme Therapeutics, Inc. HALO.MX | MX$1,275.01 75.5 USD |
0
|
MX$150.81B 8.93B USD | MX$0.00 0 USD | MX$1,275.01 75.5 USD | MX$1,275.01 75.5 USD | MX$150.81B 8.93B USD | 14.55 | MX$87.59 5.19 USD | ||
| ABIVAX Société Anonyme AAVXF | $113.00 — |
0
|
$8.90B — | $5.10K — | $110.00 — | $110.10 — | $8.90B — | 0 | -$3.56 — | ||
| 3SBio Inc. 83B.F | €3.36 3.67 USD |
-1.75
|
€8.00B 8.75B USD | €270.00 295.15 USD | €3.30 3.61 USD | €3.36 3.67 USD | €8.00B 8.75B USD | 28.00 | €0.12 0.13 USD | ||
| ALK-Abelló A/S AKBLF | $34.65 — |
0
|
$8.69B — | $100.00 — | $33.05 — | $33.05 — | $8.69B — | 45.00 | $0.77 — | ||
| Halozyme Therapeutics, Inc. RV7.F | €64.52 70.53 USD |
+4.4
|
€7.59B 8.29B USD | €45.00 49.19 USD | €64.52 70.53 USD | €64.52 70.53 USD | €7.59B 8.29B USD | 15.66 | €4.12 4.5 USD | ||
| Corcept Therapeutics Incorporated HTD.F | €69.72 76.21 USD |
+4.31
|
€7.41B 8.1B USD | €490.00 535.64 USD | €66.68 72.89 USD | €69.72 76.21 USD | €7.41B 8.1B USD | 91.73 | €0.76 0.83 USD | ||
| Cytokinetics, Incorporated KK3A.F | €58.00 63.4 USD |
0
|
€7.09B 7.75B USD | €15.00 16.4 USD | €57.50 62.86 USD | €58.00 63.4 USD | €7.09B 7.75B USD | 0 | -€5.48 -5.9 USD | ||
| SK Biopharmaceuticals Co., Ltd. 326030.KS | ₩129,000 97.37 USD |
+0.55
|
₩10T 7.63B USD | ₩0 0 USD | ₩0 0 USD | ₩0 0 USD | ₩10T 7.63B USD | 0 | ₩0 0 USD | ||
| ALK-Abelló A/S 4AJ0.F | €30.16 32.97 USD |
-1.5
|
€6.88B 7.52B USD | €51.00 55.75 USD | €30.16 32.97 USD | €30.16 32.97 USD | €6.88B 7.52B USD | 45.01 | €0.67 0.73 USD | ||
| Axsome Therapeutics, Inc. 19X.F | €132.60 144.95 USD |
+3.59
|
€6.71B 7.33B USD | €14.00 15.3 USD | €129.65 141.72 USD | €132.60 144.95 USD | €6.71B 7.33B USD | 0 | -€4.06 -4.4 USD | ||
| Merus N.V. 2GH.F | €81.00 88.54 USD |
-0.61
|
€6.27B 6.85B USD | €7.00 7.65 USD | €81.00 88.54 USD | €81.00 88.54 USD | €6.27B 6.85B USD | 0 | -€4.59 -5.01 USD | ||
| Rhythm Pharmaceuticals, Inc. 1RV.F | €89.50 97.84 USD |
+3.47
|
€6.12B 6.69B USD | €80.00 87.45 USD | €89.50 97.84 USD | €91.00 99.48 USD | €6.12B 6.69B USD | 0 | -€2.69 -2.9 USD | ||
| Sirius XM Holdings Inc. R 3HY.F | €17.85 19.51 USD |
+0.28
|
€6.05B 6.61B USD | €475.00 519.24 USD | €17.85 19.51 USD | €17.85 19.51 USD | €6.05B 6.61B USD | 5.04 | €3.54 3.87 USD | ||
| Biocon Limited BIOCON.BO | ₹393.15 4.76 USD |
-0.38
|
₹524.89B 6.35B USD | ₹30.51K 369.07 USD | ₹390.90 4.73 USD | ₹396.50 4.8 USD | ₹524.89B 6.35B USD | 98.53 | ₹3.99 0.05 USD | ||
| Arrowhead Pharmaceuticals, Inc. HDP1.F | €40.35 44.11 USD |
+4.86
|
€5.68B 6.21B USD | €20.00 21.86 USD | €38.09 41.64 USD | €40.35 44.11 USD | €5.68B 6.21B USD | 0 | -€1.04 -1.1 USD | ||
| Vaxcyte, Inc. 5VA.MU | €42.20 46.13 USD |
+0.96
|
€5.58B 6.1B USD | €0.00 0 USD | €42.20 46.13 USD | €42.20 46.13 USD | €5.58B 6.1B USD | 0 | -€4.21 -4.6 USD | ||
| Vaxcyte, Inc. 5VA.F | €40.60 44.38 USD |
0
|
€5.57B 6.09B USD | €180.00 196.76 USD | €40.60 44.38 USD | €40.60 44.38 USD | €5.57B 6.09B USD | 0 | -€4.21 -4.6 USD | ||
| ABL Bio Inc. 298380.KQ | ₩166,000 125.3 USD |
-4.1
|
₩8T 6.08B USD | ₩0 0 USD | ₩0 0 USD | ₩0 0 USD | ₩8T 6.08B USD | 0 | ₩0 0 USD | ||
| Zealand Pharma A/S ZLDPF | $83.12 — |
0
|
$5.98B — | $2.00 — | $79.36 — | $79.36 — | $5.98B — | 5.91 | $14.06 — | ||
| Krystal Biotech, Inc. 4KB.SG | €187.15 204.58 USD |
+0.19
|
€5.43B 5.93B USD | €0.00 0 USD | €185.40 202.67 USD | €187.15 204.58 USD | €5.43B 5.93B USD | 32.32 | €5.79 6.33 USD | ||
| Krystal Biotech, Inc. 4KB.F | €185.30 202.56 USD |
+1.06
|
€5.37B 5.87B USD | €300.00 327.94 USD | €185.30 202.56 USD | €185.30 202.56 USD | €5.37B 5.87B USD | 32.00 | €5.79 6.33 USD | ||
| Genscript Biotech GNNSF | $2.29 — |
0
|
$5.01B — | $333.00 — | $1.82 — | $1.82 — | $5.01B — | 0 | -$0.04 — | ||
| Legend Biotech Corporation 9LB.F | €24.20 26.45 USD |
+3.42
|
€4.47B 4.89B USD | €446.00 487.54 USD | €23.40 25.58 USD | €24.20 26.45 USD | €4.47B 4.89B USD | 0 | -€1.11 -1.2 USD | ||
| LigaChem Biosciences Inc. 141080.KQ | ₩172,900 130.51 USD |
+0.76
|
₩6T 4.75B USD | ₩0 0 USD | ₩0 0 USD | ₩0 0 USD | ₩6T 4.75B USD | 0 | ₩0 0 USD | ||
| TG Therapeutics, Inc. NKB2.F | €27.36 29.9 USD |
-2.34
|
€4.34B 4.75B USD | €616.00 673.37 USD | €27.36 29.9 USD | €27.36 29.9 USD | €4.34B 4.75B USD | 11.35 | €2.41 2.63 USD | ||
| Zealand Pharma A/S 0NZU.IL | DKK 517.50 75.88 USD |
-4.02
|
DKK 30.86B 4.52B USD | DKK 31.28K 4.59K USD | DKK 503.00 73.75 USD | DKK 529.80 77.68 USD | DKK 30.86B 4.52B USD | 0 | -DKK 15.13 -2.2 USD | ||
| ALK-Abelló A/S 0OIR.IL | DKK 149.45 21.91 USD |
0
|
DKK 30.00B 4.4B USD | DKK 13.33K 1.95K USD | DKK 225.80 33.11 USD | DKK 227.60 33.37 USD | DKK 30.00B 4.4B USD | 92.82 | DKK 1.61 0.24 USD | ||
| Asymchem Laboratories (Tianjin) Co., Ltd. 7K90.F | €8.70 9.51 USD |
+4.19
|
€3.91B 4.27B USD | €55.00 60.12 USD | €8.60 9.4 USD | €8.70 9.51 USD | €3.91B 4.27B USD | 24.85 | €0.35 0.38 USD | ||
| Akero Therapeutics, Inc. 0K4.F | €46.93 51.3 USD |
0
|
€3.86B 4.22B USD | €75.00 81.99 USD | €46.93 51.3 USD | €46.93 51.3 USD | €3.86B 4.22B USD | 0 | -€3.26 -3.5 USD | ||
| Agios Pharmaceuticals, Inc. AGIO.MX | MX$1,222.00 72.36 USD |
0
|
MX$71.26B 4.22B USD | MX$0.00 0 USD | MX$1,222.00 72.36 USD | MX$1,222.00 72.36 USD | MX$71.26B 4.22B USD | 5.16 | MX$236.58 14.01 USD | ||
| Scholar Rock Holding Corporation 2QK.F | €35.80 39.13 USD |
+3.47
|
€3.65B 3.99B USD | €150.00 163.97 USD | €35.80 39.13 USD | €35.80 39.13 USD | €3.65B 3.99B USD | 0 | -€2.74 -2.9 USD | ||
| Genscript Biotech Corporation G51.F | €1.65 1.8 USD |
-5.75
|
€3.60B 3.94B USD | €300.00 327.94 USD | €1.65 1.8 USD | €1.65 1.8 USD | €3.60B 3.94B USD | 0 | -€0.03 -0.03 USD | ||
| BB Biotech AG BB.MI | €65.20 71.27 USD |
0
|
€3.58B 3.91B USD | €10.08K 11.02K USD | €51.60 56.41 USD | €52.90 57.83 USD | €3.58B 3.91B USD | 5.75 | €11.32 12.37 USD | ||
| Centessa Pharmaceuticals plc 260.F | €15.00 16.4 USD |
0
|
€3.47B 3.79B USD | €0.00 0 USD | €15.00 16.4 USD | €15.10 16.51 USD | €3.47B 3.79B USD | 0 | -€1.64 -1.7 USD | ||
| Ligand Pharmaceuticals Incorporated LGDN.F | €174.00 190.21 USD |
+1.16
|
€3.44B 3.76B USD | €24.00 26.24 USD | €174.00 190.21 USD | €177.00 193.48 USD | €3.44B 3.76B USD | 87.87 | €1.98 2.16 USD | ||
| Crinetics Pharmaceuticals, Inc. 6Z4.F | €29.80 32.58 USD |
0
|
€3.40B 3.72B USD | €500.00 546.57 USD | €29.80 32.58 USD | €29.80 32.58 USD | €3.40B 3.72B USD | 0 | -€3.94 -4.3 USD | ||
| Viking Therapeutics, Inc. 1VT.F | €30.06 32.85 USD |
+2.05
|
€3.40B 3.71B USD | €225.00 245.96 USD | €29.56 32.31 USD | €30.06 32.85 USD | €3.40B 3.71B USD | 0 | -€1.84 -2.01 USD | ||
| ACADIA Pharmaceuticals Inc. DR6.F | €19.88 21.73 USD |
0
|
€3.36B 3.68B USD | €140.00 153.04 USD | €19.88 21.73 USD | €19.88 21.73 USD | €3.36B 3.68B USD | 14.72 | €1.35 1.48 USD | ||
| Camurus AB (publ) 7CA.F | €54.70 59.79 USD |
-1
|
€3.32B 3.63B USD | €180.00 196.76 USD | €54.70 59.79 USD | €54.70 59.79 USD | €3.32B 3.63B USD | 45.96 | €1.19 1.3 USD | ||
| Veracyte, Inc. 12V.F | €40.20 43.94 USD |
-0.5
|
€3.20B 3.5B USD | €60.00 65.59 USD | €40.20 43.94 USD | €40.20 43.94 USD | €3.20B 3.5B USD | 121.81 | €0.33 0.36 USD | ||
| Mirum Pharmaceuticals, Inc. 08D.F | €60.00 65.59 USD |
+0.84
|
€3.08B 3.37B USD | €10.00 10.93 USD | €60.00 65.59 USD | €61.00 66.68 USD | €3.08B 3.37B USD | 0 | -€0.73 -0.7 USD | ||
| Laboratorios Farmaceuticos Rovi, S.A. 41L.F | €58.50 63.95 USD |
+0.34
|
€3.07B 3.35B USD | €8.00 8.75 USD | €58.50 63.95 USD | €58.50 63.95 USD | €3.07B 3.35B USD | 24.78 | €2.36 2.58 USD | ||
| BB Biotech AG BBZA.F | €46.95 51.32 USD |
+0.64
|
€2.98B 3.26B USD | €475.00 519.24 USD | €46.60 50.94 USD | €47.00 51.38 USD | €2.98B 3.26B USD | 0 | -€8.60 -9.4 USD | ||
| Viridian Therapeutics, Inc. 1S1.F | €27.36 29.91 USD |
+5.47
|
€2.87B 3.13B USD | €38.00 41.54 USD | €27.36 29.91 USD | €27.36 29.91 USD | €2.87B 3.13B USD | 0 | -€2.63 -2.8 USD | ||
| Syngene International Limited SYNGENE.BO | ₹642.35 7.77 USD |
+0.39
|
₹258.04B 3.12B USD | ₹19.47K 235.55 USD | ₹638.40 7.72 USD | ₹644.75 7.8 USD | ₹258.04B 3.12B USD | 55.13 | ₹11.65 0.14 USD | ||
| Xenon Pharmaceuticals Inc. XP0.F | €36.00 39.35 USD |
+1.69
|
€2.85B 3.12B USD | €8.00 8.75 USD | €36.00 39.35 USD | €36.20 39.57 USD | €2.85B 3.12B USD | 0 | -€3.38 -3.6 USD | ||
| Adaptive Biotechnologies Corporation 1HM.F | €17.71 19.35 USD |
+1.49
|
€2.79B 3.05B USD | €100.00 109.31 USD | €17.62 19.26 USD | €17.71 19.35 USD | €2.79B 3.05B USD | 0 | -€0.45 -0.4 USD | ||
| Ultragenyx Pharmaceutical Inc. UP0.F | €28.20 30.83 USD |
-2.76
|
€2.78B 3.04B USD | €48.00 52.47 USD | €28.20 30.83 USD | €28.20 30.83 USD | €2.78B 3.04B USD | 0 | -€5.15 -5.6 USD | ||
| Telix Pharmaceuticals TLPPF | $8.86 — |
-0.9
|
$3.03B — | $100.00 — | $8.94 — | $8.94 — | $3.03B — | 442.75 | $0.02 — | ||
| Adaptive Biotechnologies Corporation 1HM.MU | €17.68 19.32 USD |
+10.12
|
€2.75B 3.01B USD | €0.00 0 USD | €17.68 19.32 USD | €17.68 19.32 USD | €2.75B 3.01B USD | 0 | -€0.45 -0.4 USD | ||
| SK bioscience Co.,Ltd. 302440.KS | ₩50,400 38.04 USD |
-1.56
|
₩4T 2.98B USD | ₩0 0 USD | ₩0 0 USD | ₩0 0 USD | ₩4T 2.98B USD | 0 | ₩0 0 USD | ||
| IDEAYA Biosciences, Inc. 30J.F | €30.00 32.79 USD |
-1.32
|
€2.68B 2.93B USD | €100.00 109.31 USD | €30.00 32.79 USD | €30.00 32.79 USD | €2.68B 2.93B USD | 0 | -€1.64 -1.7 USD | ||
| Amicus Therapeutics, Inc. AM6.F | €8.45 9.24 USD |
+0.6
|
€2.68B 2.93B USD | €50.00 54.66 USD | €8.45 9.24 USD | €8.45 9.24 USD | €2.68B 2.93B USD | 0 | -€0.03 -0.03 USD | ||
| IDEAYA Biosciences, Inc. 30J.SG | €30.00 32.79 USD |
+0.67
|
€2.66B 2.91B USD | €0.00 0 USD | €29.20 31.92 USD | €30.00 32.79 USD | €2.66B 2.91B USD | 0 | -€1.64 -1.7 USD | ||
| BioArctic AB (publ) 0RV2.IL | SEK 291.10 28.41 USD |
-2.18
|
SEK 29.12B 2.84B USD | SEK 12.87K 1.26K USD | SEK 286.40 27.96 USD | SEK 293.40 28.64 USD | SEK 29.12B 2.84B USD | 94.82 | SEK 3.07 0.3 USD | ||
| Catalyst Pharmaceuticals, Inc. CN2.F | €20.66 22.58 USD |
+3.61
|
€2.54B 2.78B USD | €150.00 163.97 USD | €20.09 21.96 USD | €20.66 22.58 USD | €2.54B 2.78B USD | 13.86 | €1.49 1.63 USD | ||
| Ascentage Pharma Group International 36X.F | €6.80 7.43 USD |
0
|
€2.53B 2.77B USD | €2.05K 2.24K USD | €6.80 7.43 USD | €6.80 7.43 USD | €2.53B 2.77B USD | 0 | -€0.44 -0.4 USD | ||
| Via Transportation, Inc. C0I.F | €30.80 33.67 USD |
+1.32
|
€2.49B 2.73B USD | €113.00 123.52 USD | €30.60 33.45 USD | €30.80 33.67 USD | €2.49B 2.73B USD | 0 | -€1.02 -1.1 USD | ||
| BioArctic AB (publ) B9A.F | €26.50 28.97 USD |
+4
|
€2.43B 2.65B USD | €1.80K 1.97K USD | €26.50 28.97 USD | €26.58 29.06 USD | €2.43B 2.65B USD | 25.72 | €1.03 1.13 USD | ||
| Liquidia Corporation LT4.MU | €25.68 28.07 USD |
+2.47
|
€2.39B 2.61B USD | €0.00 0 USD | €25.68 28.07 USD | €25.68 28.07 USD | €2.39B 2.61B USD | 0 | -€1.27 -1.3 USD | ||
| Denali Therapeutics Inc. 4DN.MU | €16.25 17.76 USD |
+4.77
|
€2.38B 2.61B USD | €0.00 0 USD | €16.25 17.76 USD | €16.25 17.76 USD | €2.38B 2.61B USD | 0 | -€2.54 -2.7 USD | ||
| Denali Therapeutics Inc. 4DN.F | €16.24 17.75 USD |
+0.71
|
€2.38B 2.6B USD | €750.00 819.85 USD | €16.24 17.75 USD | €16.24 17.75 USD | €2.38B 2.6B USD | 0 | -€2.54 -2.7 USD | ||
| Galapagos GLPGF | $33.45 — |
0
|
$2.53B — | $190.00 — | $26.20 — | $26.20 — | $2.53B — | 0 | -$7.84 — | ||
| Ocular Therapeutix, Inc. 0OT.F | €10.47 11.44 USD |
-2.56
|
€2.23B 2.44B USD | €15.00 16.4 USD | €10.36 11.32 USD | €10.47 11.44 USD | €2.23B 2.44B USD | 0 | -€1.24 -1.3 USD | ||
| Apellis Pharmaceuticals, Inc. 1JK.F | €16.76 18.32 USD |
+2.51
|
€2.21B 2.42B USD | €35.00 38.26 USD | €16.76 18.32 USD | €16.76 18.32 USD | €2.21B 2.42B USD | 54.05 | €0.31 0.34 USD | ||
| Liquidia Corporation LT4.SG | €25.66 28.05 USD |
+1.83
|
€2.17B 2.37B USD | €0.00 0 USD | €25.66 28.05 USD | €25.66 28.05 USD | €2.17B 2.37B USD | 0 | -€1.48 -1.6 USD | ||
| Genus GENSF | $35.15 — |
0
|
$2.33B — | $100.00 — | $26.01 — | $26.01 — | $2.33B — | 92.50 | $0.38 — | ||
| Sarepta Therapeutics, Inc. S1RP34.SA | R$5.21 1.06 USD |
+3.78
|
R$11.45B 2.32B USD | R$110.00 22.3 USD | R$5.04 1.02 USD | R$5.30 1.07 USD | R$11.45B 2.32B USD | 0 | -R$0.77 -0.1 USD | ||
| Bavarian Nordic A/S BVNKF | $29.09 — |
-1.62
|
$2.28B — | $3.00 — | $28.09 — | $28.09 — | $2.28B — | 6.15 | $4.73 — | ||
| Galapagos NV G1LP34.SA | R$8.36 1.69 USD |
+0.6
|
R$11.02B 2.23B USD | R$2.00 0.41 USD | R$8.36 1.69 USD | R$8.36 1.69 USD | R$11.02B 2.23B USD | 0 | -R$2.10 -0.4 USD | ||
| Bavarian Nordic A/S BVNRY | $9.49 — |
-0.68
|
$2.23B — | $1.00 — | $9.44 — | $9.44 — | $2.23B — | 6.00 | $1.58 — | ||
| 89bio ETNB | $14.84 — |
0
|
$2.20B — | $0.00 — | $0.00 — | $0.00 — | $2.20B — | 0 | $0.00 — | ||
| Bavarian Nordic A/S BV3.F | €24.43 26.71 USD |
+0.41
|
€1.94B 2.13B USD | €7.00 7.65 USD | €24.31 26.57 USD | €24.43 26.71 USD | €1.94B 2.13B USD | 5.94 | €4.11 4.49 USD | ||
| BAVARIAN NORDIC N BV3.DE | €24.67 26.97 USD |
-0.72
|
€1.93B 2.11B USD | €145.00 158.5 USD | €24.46 26.74 USD | €24.67 26.97 USD | €1.93B 2.11B USD | 6.00 | €4.11 4.49 USD | ||
| Genus plc GBE.F | €28.20 30.83 USD |
+1.44
|
€1.87B 2.05B USD | €211.00 230.65 USD | €27.60 30.17 USD | €28.20 30.83 USD | €1.87B 2.05B USD | 85.45 | €0.33 0.36 USD | ||
| Zai Lab Limited 1ZL.F | €16.90 18.47 USD |
-1.17
|
€1.87B 2.05B USD | €50.00 54.66 USD | €16.90 18.47 USD | €16.90 18.47 USD | €1.87B 2.05B USD | 0 | -€1.65 -1.8 USD | ||
| Aurinia Pharmaceuticals Inc. IKAP.F | €13.85 15.14 USD |
-0.68
|
€1.83B 2.01B USD | €50.00 54.66 USD | €13.73 15.01 USD | €13.85 15.14 USD | €1.83B 2.01B USD | 28.26 | €0.49 0.54 USD | ||
|
お気に入り銘柄なし
お気に入りの株式はまだありません。ここで表示するにはお気に入りに追加してください |
|||||||||||